Welcome to AHRMM's Knowledge Center. Find all the resources you’re looking for by applying filters for precise and efficient search functionality.
15 results returned
The AHRMM Cost, Quality and Outcomes (CQO) Movement was launched in 2013 to advance the role of the health care supply chain in delivering higher quality care at a more affordable cost, and in a manner that delivers the highest value to patients. In the 2019 CQO Report, entitled, “The Power of Clinical Integration,” members of the CQO Strategy Group took a step back to reflect on the arc of the CQO Movement and examine how the role of health care supply chain professionals has expanded over the past six years, and how it continues to grow as the need for their expertise becomes greater. The report follows the evolution of the CQO Movement through the Affordable Care Act, Triple and Quadruple Aims, population health management, and the clinically integrated supply chain.
Read this report on the recommended practices related to the allocation of multiple unique device indicators (UDI-DI) and suggested ways to mitigate the occurrence or negative implication of multiple UDI-DIs.
The goal of this report is to share best practices, while generating continued dialogue within the AHRMM community and across the broader health care field on clinical integration in the supply chain as a critical component of the CQO Movement. The case studies included in the report provide insights into the evolution of the CQO Movement and create opportunities for you to engage with others across your organization and across the health care field to create leading practices of your own.
The report from the Business Case for the UDI work group, a formal work group of AHRMM's Learning UDI Community (LUC) is intended to close the knowledge gap between the current realities of supply chain workflow processes, and offer a vision for how UDI adoption will allow for a smoothly functioning supply chain based upon reliable product information. The report addresses five process flows that could potentially change following healthcare organizations’ adoption of the UDI. Descriptions of workflow processes highlight the redundancies in today’s environment and where changes using UDI will lead to streamlined future operations and potential savings opportunities. The report also contains recommendations on what hospitals need to do to effectively adopt UDI and incorporate it into ongoing clinical and supply chain operations.
Human cells, tissues, or cellular or tissue-based products (HCT/Ps) are a precious resource often provided by deceased donors and/or acutely grieving family members. Living donors also provide HCT/Ps that can improve and save lives of recipients in need. Tissue banks, eye banks and cellular therapy laboratories handle these products of human origin with care and respect, understanding the special gift of donation. It is important this care and respect is followed from the time of donation and recovery to the moment of implant, transplant, infusion, or transfer to a human recipient. This guidance document, developed by a work group of the AHRMM Learning UDI Community (LUC) provides information on HCT/Ps, HCT/Ps regulation as a medical device, traceability of HCT/Ps, and the U.S. Food and Drug Administration (FDA) Unique Device Identification (UDI) Rule and its effects on HCT/Ps regulated as a medical device.
February 25, 2018 | Content Areas: Logistics | Tags: Data Standards, Regulatory, Suppliers, UDI | Formats: Report/Study
The goal of this document is to provide a guide for supply chain partners to begin a dialogue to ensure that medical devices comply with FDA’s Unique Device Identification (UDI) requirements as well as meet the FDA’s goal of enhancing patient safety. Low Unit of Measure (LUM) programs are complex and the steps outlined in this best practices document are a critical first step. We expect this to be an ongoing process as additional opportunities for stakeholder collaboration continue to arise.
AHRMM assembled a task force comprised of experts in the fields of healthcare supply chain, finance, and value analysis to examine the current population health management landscape in order to determine what impact these programs are having on the physical and behavioral health of people and the financial health of hospitals, health systems, and other community-based health related organizations. In this report we present their findings, including insights from healthcare thought leaders, guiding principles for population health management success, and case studies documenting population health management programs across the six domains of care.